We are live on
!
Find out more
Lazard Asset Management Portfolio holdings
AUM
$60.8B
1-Year Est. Return
22.47%
This Fund
S&P 500
This Quarter
Est. Return
+14.09%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+305.76%
AUM
$79.1B
AUM Growth
+$7.99B
(+11%)
Cap. Flow
-$5.86B
Cap. Flow
% of AUM
-7.4%
Top 10 Holdings %
Top 10 Hldgs %
22.63%
Holding
2,061
New
445
Increased
504
Reduced
465
Closed
231
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sysco
SYY
|
+$273M |
| 2 |
Waste Management
WM
|
+$168M |
| 3 |
Lowe's Companies
LOW
|
+$160M |
| 4 |
PNC Financial Services
PNC
|
+$154M |
| 5 |
Unilever
UL
|
+$122M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$548M |
| 2 |
Apple
AAPL
|
+$372M |
| 3 |
CSX Corp
CSX
|
+$369M |
| 4 |
Infosys
INFY
|
+$238M |
| 5 |
Kimberly-Clark
KMB
|
+$235M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.16% |
| 2 | Healthcare | 14.65% |
| 3 | Financials | 13.08% |
| 4 | Industrials | 9.66% |
| 5 | Consumer Discretionary | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
AT&T
T
$162B
| $44M | 0.06% |
2,023,903
+59,038
| +3% | +$1.27M |
|
227
Allstate
ALL
$70.9B
| $43.7M | 0.06% |
397,500
-2,739
| -0.7% | -$269K |
|
228
Atkore
ATKR
$3.16B
| $43.1M | 0.05% |
1,048,174
-287,357
| -22% | -$9.06M |
|
|
PGTI
229
DELISTED
PGT, Inc.
PGTI
| $43.1M | 0.05% |
2,118,505
+360,918
| +21% | +$6.72M |
|
230
iShares Core US Aggregate Bond ETF
AGG
$137B
| – | – |
0
| – | – |
|
|
GF
231
New Germany Fund
GF
$187M
| $42.8M | 0.05% |
2,249,137
+5,970
| +0.3% | +$109K |
|
232
Parsons
PSN
$5.11B
| $42.6M | 0.05% |
1,170,041
+209,169
| +22% | +$7.03M |
|
233
Idexx Laboratories
IDXX
$46.5B
| $42M | 0.05% |
84,009
-64,969
| -44% | -$29.1M |
|
234
Shinhan Financial Group
SHG
$34.9B
| $42M | 0.05% |
1,410,282
-204,710
| -13% | -$5.84M |
|
235
Citigroup
C
$224B
| $41.6M | 0.05% |
675,301
-551,642
| -45% | -$28M |
|
|
EGOV
236
DELISTED
NIC Inc
EGOV
| $41.6M | 0.05% |
1,611,976
+89,650
| +6% | +$2.08M |
|
237
WIX.com
WIX
$2.55B
| $41.6M | 0.05% |
166,276
-42,641
| -20% | -$11.2M |
|
238
Nike
NKE
$62.3B
| $41.5M | 0.05% |
293,391
+110,339
| +60% | +$14.6M |
|
|
NSA
239
DELISTED
National Storage Affiliates Trust
NSA
| $41.4M | 0.05% |
1,150,072
+69,170
| +6% | +$2.39M |
|
240
Vipshop
VIPS
$7.4B
| $41.4M | 0.05% |
1,473,729
+238,657
| +19% | +$5.29M |
|
|
CCMP
241
DELISTED
CMC Materials, Inc. Common Stock
CCMP
| $40.7M | 0.05% |
268,885
-16,089
| -6% | -$2.41M |
|
|
NBIS
242
Nebius Group N.V.
NBIS
$48.2B
| $40.5M | 0.05% |
582,025
-38,000
| -6% | -$2.43M |
|
243
RTX Corp
RTX
$301B
| $40.5M | 0.05% |
566,022
-47,372
| -8% | -$3.11M |
|
244
Allegion
ALLE
$14.3B
| $40.4M | 0.05% |
346,805
+333,748
| +2,556% | +$36.3M |
|
245
Amdocs
DOX
$6.28B
| $40M | 0.05% |
564,201
+196,966
| +54% | +$12.4M |
|
|
ATVI
246
DELISTED
Activision Blizzard
ATVI
| $39.4M | 0.05% |
424,380
+11,770
| +3% | +$956K |
|
247
Morningstar
MORN
$7.38B
| $39.2M | 0.05% |
169,114
-27,347
| -14% | -$5.43M |
|
248
Charles River Laboratories
CRL
$12.8B
| $39.1M | 0.05% |
156,628
-10,757
| -6% | -$2.56M |
|
249
Union Pacific
UNP
$176B
| $39M | 0.05% |
187,337
+484
| +0.3% | +$96.7K |
|
|
CHN
250
DELISTED
China Fund
CHN
| $38.7M | 0.05% |
1,355,294
+147,725
| +12% | +$4.23M |
|
Similar funds
QCM
Lazard Asset Management's Q4 2020 Portfolio in Review
As of Q4 2020, Lazard Asset Management held 2,061 positions worth $79.1B, up 11% from $71.1B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Lazard Asset Management withdrew a net $5.86B in Q4 2020, closing 231 positions and reducing 465 holdings. Its most notable exit was Unilever NV New York Registry Shares, an estimated $112M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Lazard Asset Management opened a new position in Sotera Health worth $100M.
- Lazard Asset Management's largest Q4 2020 buy was Sotera Health: 3,651,831 shares worth $100M.
- Lazard Asset Management added most to Sysco in Q4 2020, an estimated $273M increase.
- Lazard Asset Management's biggest Q4 2020 reduction was Pfizer, cutting an estimated $548M.
- Lazard Asset Management fully exited Unilever NV New York Registry Shares in Q4 2020, selling an estimated $112M.
- Lazard Asset Management's ten largest holdings make up 23% of its $79.1B portfolio in Q4 2020.
- Lazard Asset Management opened 445 new positions and closed 231 in Q4 2020.
- Lazard Asset Management's portfolio value rose 11% quarter-over-quarter to $79.1B.
Based on Lazard Asset Management's 13F filing for Q4 2020, filed 11 Feb 2021.